| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 Nov 2025 | 8 Nov 2025 |
| Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30 2025. The Board Meeting to be held on 12/11/2025 has been revised to 13/11/2025 The Board Meeting scheduled to be held on 12/11/2025 has been postponed and rescheduled to be held on 13/11/2025 (As Per Bse Announcement dated on 10/11/2025) Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended September 2025 (As per BSE Announcement dated on: 13.11.2025) | ||
| Board Meeting | 28 Jul 2025 | 22 Jul 2025 |
| Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on June 30 2025. Outcome of Board Meeting held on Monday, July 28, 2025 (As Per BSE Announcement Dated on: 28.07.2025) | ||
| Board Meeting | 2 May 2025 | 28 Apr 2025 |
| Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2025 ,inter alia, to consider and approve 1. To consider and approve the audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended on March 31, 2025. 2. To recommend dividend, if any, on equity shares of the Company for the financial year 2024-25. 3. To fix date of 5th Annual General Meeting. A.G.M. & Audited Results & Final Dividend The Board of Directors at its meeting held today i.e. Friday, May 02, 2025 recommends the final dividend of Rs. 1.25 per equity shares. (As Per BSE Announcement Dated on 02.05.2025) | ||
| Board Meeting | 2 Apr 2025 | 27 Mar 2025 |
| Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/04/2025 inter alia to consider and approve the Employee Stock Option Scheme in terms of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations 2021. outcome of Board Meeting held on April 02, 2025 (As Per Bse Announcement Dated on 02.04.2025) | ||
| Board Meeting | 4 Feb 2025 | 30 Jan 2025 |
| Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 inter alia to consider and approve 1. the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2024. 2. the Employee Stock Option Scheme in terms of SEBI (Share Based Employee Benefits and Sweat Equity) regulations 2021. Outcome of the Board Meeting held on Tuesday, February 04, 2025 interalia approving standalone and consolidated financial results for the quarter and nine months ended December 31, 2024. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform that the Board at its meeting held on Tuesday, February 04, 2025 approved the re-appointment of non-executive Independent Directors of the Company. (As Per BSE Announcement dated on 04.02.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.